Quantcast
Channel: Endpoints News
Viewing all articles
Browse latest Browse all 5860

Aspect Bio takes Novo castoff therapies; Takeda trims US jobs

$
0
0
Plus, news about AstraZeneca, AbelZeta, Novavax, Pfizer, Alteogen, Tesaro, Epidarex Capital and Boundless Bio: 🤝 Aspect Biosystems picks up Novo Nordisk’s castoff cell therapies: The Vancouver biotech has taken over stem cell-derived islet cell and ...

Viewing all articles
Browse latest Browse all 5860

Trending Articles